Search
for
Sort by
Research 61–90 of 1000+
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Alopecia caused by isoniazid
- Drug-induced scarring and permanent alopecia
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- A machine learning and network framework to discover new indications for small molecules
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- AB0163 ANTI-KU ANTIBODIES: MUCH MORE THAN SCLEROMYOSITIS
- Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Cemotherapi Induce Alopecia Due Carboplatin-Paclitaxel Regiment
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- The PDGF/PDGFR pathway as a drug target
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Dual drug co-encapsulation into liposomes and liposome-derived nanosystems for improved synergistic treatment of skin diseases
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Specific inhibition of FGF5-induced cell proliferation by RNA aptamers
- Novel drugs of United States Food and Drug Administration approved in 2024
- Cordyceps militaris Grown on Germinated Rhynchosia nulubilis (GRC) Encapsulated in Chitosan Nanoparticle (GCN) Suppresses Particulate Matter (PM)-Induced Lung Inflammation in Mice
- Radioprotection of Lung Tissue by Soy Isoflavones
- Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel